Cegedim : 2022 - 27 JANVIER CA consolidé Présentation du CA 2021
January 27, 2022 at 03:43 pm EST
Share
FY 2021 Revenue
January 27,2022
Forward-looking statements
This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on expectations and assumptions that we believe to be reasonable when made, but that may not prove to be accurate. By their nature, forward-looking statements involve risk and uncertainty. Consequently, the company cannot guarantee their accuracy and their completeness, and actual results may differ materially from those the company anticipated due to a number of uncertainties, many of which the company is not aware of.
For additional information concerning important factors that may cause the company's actual results to differ materially from expectations and underlying assumptions, please refer to the reports filed by the company with the Autorité des Marchés Financiers.
Any forward-looking statement speaks only as of the date on which it is made, and we assume no obligation to update or revise any forward- looking statement, whether as a result of new information, future events, or otherwise, except as required by law.
Cegedim SA published this content on 27 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 January 2022 20:41:49 UTC.
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows:
- Insurance companies and services (72.1%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS);
- Health care professionals (26.8%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.;
- other (1.1%).
France accounts for 89.7% of net sales.
CEGEDIM 
